bblagg	10.1016/j.bmc.2016.11.030	<http://dx.doi.org/10.1016/j.bmc.2016.11.030>; rel="canonical", <https://api.elsevier.com/content/article/PII:S0968089616308392?httpAccept=text/xml>; version="vor"; type="text/xml"; rel="item", <https://api.elsevier.com/content/article/PII:S0968089616308392?httpAccept=text/plain>; version="vor"; type="text/plain"; rel="item", <https://www.elsevier.com/tdm/userlicense/1.0/>; version="tdm"; rel="license", <https://www.elsevier.com/open-access/userlicense/1.0/>; version="am"; rel="license"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.bmc.2016.11.030"><j.2:doi>10.1016/j.bmc.2016.11.030</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/gaurav-garg-2q26b45eh9vv"><j.3:name>Gaurav Garg</j.3:name><j.3:familyName>Garg</j.3:familyName><j.3:givenName>Gaurav</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>451</j.1:startingPage><j.2:pageStart>451</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/brian-s-j-blagg-2q26b45eh9vv"><j.3:name>Brian S.J. Blagg</j.3:name><j.3:familyName>Blagg</j.3:familyName><j.3:givenName>Brian S.J.</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>25</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/huiping-zhao-2q26b45eh9vv"><j.3:name>Huiping Zhao</j.3:name><j.3:familyName>Zhao</j.3:familyName><j.3:givenName>Huiping</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1016/j.bmc.2016.11.030"/><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0968-0896"><owl:sameAs>urn:issn:0968-0896</owl:sameAs><j.0:title>Bioorganic &amp; Medicinal Chemistry</j.0:title><j.1:issn>0968-0896</j.1:issn><j.2:issn>0968-0896</j.2:issn></j.2:Journal></j.0:isPartOf><j.1:endingPage>457</j.1:endingPage><owl:sameAs rdf:resource="info:doi/10.1016/j.bmc.2016.11.030"/><j.2:pageEnd>457</j.2:pageEnd><j.0:title>Design, synthesis and biological evaluation of alkylamino biphenylamides as Hsp90 C-terminal inhibitors</j.0:title><j.0:publisher>Elsevier BV</j.0:publisher><j.2:volume>25</j.2:volume><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2017-01</j.0:date><j.0:identifier>10.1016/j.bmc.2016.11.030</j.0:identifier><j.1:doi>10.1016/j.bmc.2016.11.030</j.1:doi></rdf:Description></rdf:RDF>
